Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Molecular imaging in drug development
2008 Standout
Histoplasmosis: Experience During Outbreaks in Indianapolis and Review of the Literature
1997
Laccase and melanin in the pathogenesis of Cryptococcus neoformans
1997
FUNGAL INFECTIONS OF THE CENTRAL NERVOUS SYSTEM
1999
Practice Guidelines for the Management of Patients with Histoplasmosis
2000
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
CNS pharmacokinetics of antifungal agents
2007
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Cerebral Histoplasmosis in the Azole Era: Report of Four Cases and Review
2003
Hepatobiliary complications in patients with human immunodeficiency virus infection
1992
CLINICAL RELEVANCE OF ANTIFUNGAL RESISTANCE
1997
Acute Respiratory Failure Associated with Cryptococcosis in Patients with AIDS: Analysis of Predictive Factors
1998
Itraconazole Maintenance Treatment for Histoplasmosis in AIDS: A Prospective, Multicenter Trial
1997
Recent Advances in the Management of Cryptococcal Meningitis in Patients with AIDS
1996
Blastomycosis in Transplant Recipients: Report of a Case and Review
1993
Properties and applications of calcium hydroxide in endodontics and dental traumatology
2011 Standout
Functional Properties of the T Cell Receptor Repertoire in Responding to the Protective Domain of Heat‐Shock Protein 60 fromHistoplasma capsulatum
2002
Imaging in the era of molecular oncology
2008 StandoutNature
Antifungal Agents. Part II. The Azoles
1999
Antifungal Resistance in Pathogenic Fungi
2002
Exercise Standards for Testing and Training
2013 Standout
Fungal infections in AIDS patients
1992
Using imaging biomarkers to accelerate drug development and clinical trials
2005
Macrophages in immunoregulation and therapeutics
2023 Standout
Oral multispecies biofilm development and the key role of cell–cell distance
2010 Standout
Far-red to near infrared analyte-responsive fluorescent probes based on organic fluorophore platforms for fluorescence imaging
2012 Standout
Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing
1996
Recent developments in pradimicin-benanomicin and triazole antibiotics
1997
Treatment of murine cryptococcal meningitis with UR-9751 and UR-9746
2000
Survival factors in rhino-orbital-cerebral mucormycosis
1994
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Unusual manifestations of disseminated Histoplasmosis in patients responding to antiretroviral therapy
2005
Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome
1995
Histoplasmosis and Blastomycosis
1996
Cryptococcosis: Population‐Based Multistate Active Surveillance and Risk Factors in Human Immunodeficiency Virus–Infected Persons
1999
Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070
2021
Pharmacokinetic Imaging
2002
Increased Incidence of Disseminated Histoplasmosis Following Highly Active Antiretroviral Therapy Initiation
2006
Clinical Pharmacokinetics of Fluconazole in Superficial and Systemic Mycoses
1997
Echinocandin antifungal drugs
2003 Standout
Bioluminescent Imaging of Ubiquitin Ligase Activity: Measuring Cdk2 Activity In Vivo Through Changes in p27 Turnover
2005 StandoutNobel
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum
2003
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
The Future of Antifungal Therapy
1996
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Histoplasmosis Relapse in Patients with AIDS: Detection Using Histoplasma capsulatum variety capsulatum Antigen Levels
1991
Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center
2005
Role of Azoles in Antifungal Therapy
1996
Immunodiagnosis of invasive fungal infection
1992
Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy
2004
Isolated central nervous system histoplasmosis in immunocompetent hosts: A series of 11 cases
2005
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Recent Advances in Pulmonary Medicine
1993
Immunity to fungal infections
2011 Standout
Itraconazole therapy for blastomycosis and histoplasmosis
1992
A Case of HIV-Associated Cerebral Histoplasmosis Successfully Treated with Fluconazole
1999
FUNGAL INFECTIONS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
1997
Molecular imaging in drug discovery and development
2003
Infection in Organ-Transplant Recipients
1998 Standout
Cryptococcosis
2002
Fluconazole Therapy for Histoplasmosis
1996
Diagnosis and Management of Central Nervous System Histoplasmosis
2005
Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study
1995
Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDS
2002
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
A Controlled Trial of Itraconazole as Primary Prophylaxis for Systemic Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection in Thailand
2002
Fluconazole
1995
Disseminated histoplasmosis in renal allograft recipients
1996
CNS pharmacokinetics of antifungal agents
2007
Antifungal drug resistance
1995
Histoplasmosis: a Clinical and Laboratory Update
2007
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
2002 Standout
Candida Infections of Medical Devices
2004 Standout
Fungal infections: a growing threat.
1996
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Case 4-1994
1994
Antigen Clearance during Treatment of Disseminated Histoplasmosis with Itraconazole versus Fluconazole in Patients with AIDS
2002
Human microsporidial infections
1994 Standout
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma.
1998
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice
1994
The Epidemiological Features of Invasive Mycotic Infections in the San Francisco Bay Area, 1992-1993: Results of Population-Based Laboratory Active Surveillance
1998
Zygomycetes in Human Disease
2000 Standout
Improvements in diagnosis of histoplasmosis
2006
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Fungal Infections of the Genitourinary System
1993
Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study
1996
Atg7 Deficiency Intensifies Inflammasome Activation and Pyroptosis in Pseudomonas Sepsis
2017
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
DISSEMINATED HISTOPLASMOSIS: A COMPARATIVE STUDY BETWEEN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME AND NON-HUMAN IMMUNODEFICIENCY VIRUS–INFECTED INDIVIDUALS
2005
Endemic mycoses in AIDS: a clinical review
1995
Mycotoxins
2003 Standout
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
1998
Comparison of a New Triazole, Posaconazole, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in Immunocompromised Mice
2000
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole
1994
Antifungal Distribution Into Cerebrospinal Fluid, Vitreous Humor, Bone, and Other Difficult Sites
2010
Case 51-1993
1993
Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia
2005 Standout
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
2005 Standout
Oral mucosal fungal infections
2008
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
A 43-Year-Old Woman With Acquired Immunodeficiency Syndrome and Fever of Undetermined Origin
2006
Aspergillus fumigatusand Aspergillosis
1999 Standout
Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection
2000
Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B
1994
Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum
1997
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
A Monoclonal Antibody toHistoplasma capsulatumAlters the Intracellular Fate of the Fungus in Murine Macrophages
2008
Guidelines for Treatment of Candidiasis
2004 Standout
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
2001
Detection and identification of fungal pathogens in blood by using molecular probes
1997 Standout
Fluconazole penetration in cerebral parenchyma in humans at steady state
1995
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Treatment of Histoplasmosis with MK-991 (L-743,872)
1998
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Galleria mellonella as a Model System To Study Cryptococcus neoformans Pathogenesis
2005 Standout
Exercise Testing, Training and Arm Ergometry
1985
Works of Douglas Webb being referenced
Pharmacokinetics of 18F-labeled fluconazole in rabbits with candidal infections studied with positron emission tomography.
1991
Disseminated Histoplasmosis in the Acquired Immune Deficiency Syndrome
1990
Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome
1994
Using economic evidence to support policy decisions to fund interventions for non-communicable diseases
2019
Synthesis of 18F-labeled fluconazole and positron emission tomography studies in rabbits
1992
Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole
1993
Treatment of Pseudomonas Infections in Peritoneal Dialysis Patients
1991
Benefits of Arm Exercise in Cardiac Rehabilitation
1977
New antifungal agents: Clinical and laboratory issues
1991
Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography
1993